Skip to main content

UKRAIN is registered in many countries:

UKRAINE
2008 - #UA/9110/01/01
2003 - #3641, 1998 - #3641

 

GEORGIA
2008 - #461/o, 1999 - #002861

 

UNITED ARAB EMIRATES
2007 - #4987-6179-1-C2

 

MEXICO
2005 - #036M2005 SSA

 

AZERBAIJAN
2000 - #00267

 

TAJIKISTAN
2000 - #000568

 

TURKMENISTAN
2000 - #0001707

 

BELARUS
1995 - #1330-95

 

 

Anticancer drug Ukrain® has been approved as standard anticancer medication in United Arab Emirates (registration no. 4987-6179-1), some countries of Europe (for example, Ukraine: first approval on October 18, 1998, #3641, re-approval on September 2, 2003, #3641), Mexico (No. 036M2005 SSA).

Ukrain® has also been designated as an Orphan Drug for pancreatic cancer in the USA (Designation Request #03-1693) and also in Australia (File 004/009839).

Ukrain® has been presented 264 times at international scientific congresses and symposia as for example International Congresses of Chemotherapy, Annual Meetings of the American Association for Cancer Research, NCI – EORTC Symposium on New Drugs in Cancer Therapy and many others. 1997, at the 20th International Congress on Chemotherapy in Sydney, Australia, a whole sectional meeting was devoted to UKRAIN. Ukrain has been subject of 257 research publications.